Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes.

Mune T, Suwa T, Morita H, Isomura Y, Takada N, Yamamoto Y, Hayashi M, Yamakita N, Sasaki A, Takeda N, Takeda J, White PC, Kaku K.

Endocr J. 2013;60(5):671-8. Epub 2013 Jan 26.

2.

HSD11B2 CA-repeat and sodium balance.

Mune T, Morita H, Takada N, Yamamoto Y, Isomura Y, Suwa T, Takeda J, White PC, Kaku K.

Hypertens Res. 2013 Jul;36(7):614-9. doi: 10.1038/hr.2013.13. Epub 2013 Feb 28.

PMID:
23446772
3.

Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.

Bardini G, Dicembrini I, Pala L, Cresci B, Rotella CM.

Diabet Med. 2011 Oct;28(10):1229-33. doi: 10.1111/j.1464-5491.2011.03332.x.

PMID:
21923697
4.

Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.

Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, Miyamoto S, Nohara A, Kawashiri MA, Takeda Y, Yamagishi M.

Endocr J. 2012;59(1):55-64. Epub 2011 Nov 9.

5.

[Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].

Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese.

PMID:
17686259
6.

Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.

Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.

Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E758-64. doi: 10.1152/ajpendo.90737.2008. Epub 2009 Feb 3.

7.

Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.

Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group.

Diabetes. 2002 Jul;51(7):2170-8.

9.

Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.

Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM.

Diabetes. 2008 Oct;57(10):2652-60. doi: 10.2337/db08-0495. Epub 2008 Jul 15.

10.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M.

Gynecol Endocrinol. 2005 Oct;21(4):206-10.

PMID:
16316841
11.

Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.

Yamada K, Yuan X, Ishiyama S, Shoji S, Kohno S, Koyama K, Koyanagi A, Koyama W, Nonaka K.

Diabetes Care. 1998 May;21(5):753-6.

PMID:
9589236
12.

Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.

Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, Guthoff M, Silbernagel G, Stefan N, Häring HU, Fritsche A.

PLoS One. 2008;3(12):e3962. doi: 10.1371/journal.pone.0003962. Epub 2008 Dec 17.

14.

Association of the clusterin gene polymorphisms with type 2 diabetes mellitus.

Daimon M, Oizumi T, Karasawa S, Kaino W, Takase K, Tada K, Jimbu Y, Wada K, Kameda W, Susa S, Muramatsu M, Kubota I, Kawata S, Kato T.

Metabolism. 2011 Jun;60(6):815-22. doi: 10.1016/j.metabol.2010.07.033. Epub 2010 Sep 20.

PMID:
20850846
15.

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Diabetes Care. 2003 Mar;26(3):868-74.

PMID:
12610051
16.

Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes.

Chung HK, Chae JS, Hyun YJ, Paik JK, Kim JY, Jang Y, Kwon HM, Song YD, Lee HC, Lee JH.

Diabetes Care. 2009 Apr;32(4):552-8. doi: 10.2337/dc08-1605. Epub 2009 Jan 8.

17.

Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.

Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B.

J Clin Lab Anal. 2007;21(2):85-90.

PMID:
17385686
18.

Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.

Carvajal CA, Romero DG, Mosso LM, González AA, Campino C, Montero J, Fardella CE.

J Hypertens. 2005 Jan;23(1):71-7.

PMID:
15643127
19.

Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.

Nordman S, Ding B, Ostenson CG, Kärvestedt L, Brismar K, Efendic S, Gu HF.

Exp Clin Endocrinol Diabetes. 2005 May;113(5):282-7.

PMID:
15926114
20.

The homeostasis model in the San Antonio Heart Study.

Haffner SM, Miettinen H, Stern MP.

Diabetes Care. 1997 Jul;20(7):1087-92.

PMID:
9203442

Supplemental Content

Support Center